Which is the proper reference tissue for measuring the change in FDG PET metabolic volume of cardiac sarcoidosis before and after steroid therapy?

BACKGROUND: Cardiac sarcoidosis (CS) is a rare but potentially life-threatening disease that causes conduction disturbance, systolic dysfunction, and, most notably, sudden cardiac death. (18)F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) plays important roles no...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:EJNMMI Res
Autors principals: Furuya, Sho, Manabe, Osamu, Ohira, Hiroshi, Hirata, Kenji, Aikawa, Tadao, Naya, Masanao, Tsujino, Ichizo, Koyanagawa, Kazuhiro, Anzai, Toshihisa, Oyama-Manabe, Noriko, Shiga, Tohru
Format: Artigo
Idioma:Inglês
Publicat: Springer Berlin Heidelberg 2018
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6173675/
https://ncbi.nlm.nih.gov/pubmed/30291527
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13550-018-0447-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars